Novo Holdings A/S 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-03 3:01 pm Sale |
2022-05-31 | 13D | Checkmate Pharmaceuticals, Inc. CMPI |
Novo Holdings A/S | 0 0.000% |
-1,828,484 (Position Closed) |
Filing |
| 2022-05-11 2:57 pm Sale |
2022-05-05 | 13D | Checkmate Pharmaceuticals, Inc. CMPI |
Novo Holdings A/S | 1,828,484 8.300% |
-341,616 (-15.74%) |
Filing |
| 2021-11-01 4:03 pm Unchanged |
2021-11-01 | 13D | Checkmate Pharmaceuticals, Inc. CMPI |
Novo Holdings A/S | 2,170,100 10.000% |
0 (Unchanged) |
Filing |
| 2020-08-13 4:47 pm Purchase |
2020-08-11 | 13D | Checkmate Pharmaceuticals, Inc. CMPI |
Novo Holdings A/S | 2,170,100 10.100% |
2,170,100 (New Position) |
Filing |